Personal profile
Personal profile
Dr. Eagar received his PhD in immunology and molecular pathogenesis from the Northwestern University Medical School in Chicago in 2001. He then completed an immunology fellowship at the University of California at San Francisco and an HLA fellowship at Houston Methodist Hospital. Dr. Eagar was an assistant professor in the Department of Pathology and Immunology at The University of Texas Southwestern Medical Center in Dallas before joining the Department of Pathology and Genomic Medicine here in 2013.
Research interests
Dr. Eagar is board certified in histocompatibility by the American Board of Histocompatibility and Immunogenetics. His research interests include identifying immune processes involved in the pathogenesis of multiple sclerosis and transplant rejection, with a focus on finding novel regulatory pathways involved in T cell activation that might be harnessed for therapeutic intervention.
Research Area Keywords
- Infectious Disease & Pathology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Imlifidase Utilization in Glanzmann Thrombasthenia With Anti-GPIIb/IIIa and Anti-HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant
AlNajjar, M., Rochat, R., Grimes, A. B., Navaei, A., Eagar, T., Martinez, C., Yassine, K., Krance, R. & Bhar, S., Mar 2025, In: Pediatric Blood and Cancer. 72, 3, p. e31412 e31412.Research output: Contribution to journal › Letter › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts
Xiong, Z., Walsh, K. M., Sneiderman, C. T., Nisnboym, M., Hadjipanayis, C. G., Agnihotri, S., Eagar, T. N., Wang, H., Pollack, I. F., Forsthuber, T. G., Li, X., Raphael, I. & Kohanbash, G., Jun 1 2025, In: Neuro-oncology. 27, 6, p. 1628-1639 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Single-Cell Splicing Isoform Atlas of the Adult Human Heart and Heart Failure
Pan, T., Lu, L., Youker, K. A., Shiau, C. K., Wang, M., Lin, H. Y., Nguyen, A., He, Y., Tong, E., Zhu, P., Ranka, R., Yan, Y., Sinha, A., Bharat, A., Eagar, T., Wilcox, J., Bhimaraj, A. & Gao, R., Sep 29 2025, In: Circulation. Publish Ahead of PrintResearch output: Contribution to journal › Article › peer-review
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates
Fida, N., Eagar, T. N., Yun, A. N., Rogers, A. W., Nguyen, D. T., Graviss, E. A., Ishaq, F., DiPaola, N. R., Kim, J., Gorthi, J. R., Kassi, M., Yousefzai, R., Suarez, E. E., Bhimaraj, A., Krisl, J. C. & Guha, A., Feb 2024, In: Clinical Transplantation. 38, 2, p. e15249 e15249.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Vasileiou, S., Hill, L. Q., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B. J., Heslop, H. E., Rooney, C. M., Brenner, M. K., Eagar, T. N., Carrum, G., Grimes, K. A., Leen, A. M. & Lulla, P., Jul 1 2023, In: Haematologica. 108, 7, p. 1840-1850 11 p.Research output: Contribution to journal › Article › peer-review
Open Access26 Link opens in a new tab Scopus citations